AwesomeCapital
Search This Blog
Friday, June 14, 2019
bluebird bio (BLUE) EHA ‘Solid Win’, But Zynteglo’s Launch in EU Delayed – Cowen
Cowen analyst Yaron Werber reiterated an Outperform rating
https://www.streetinsider.com/Analyst+Comments/bluebird+bio+%28BLUE%29+EHA+a+Solid+Win%2C+But+Zynteglo%E2%80%99s+Launch+in+EU+Delayed+-+Cowen/15613630.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.